Avolio, Alfonso Wolfango
 Distribuzione geografica
Continente #
EU - Europa 4.275
NA - Nord America 4.053
AS - Asia 975
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 9
AF - Africa 8
OC - Oceania 8
Totale 9.338
Nazione #
US - Stati Uniti d'America 3.997
DE - Germania 1.381
SE - Svezia 869
CN - Cina 695
UA - Ucraina 522
IT - Italia 423
IE - Irlanda 257
FR - Francia 231
GB - Regno Unito 196
PL - Polonia 148
FI - Finlandia 128
TR - Turchia 65
IN - India 61
CA - Canada 40
BE - Belgio 39
SG - Singapore 35
HK - Hong Kong 30
IR - Iran 26
KR - Corea 22
JP - Giappone 19
RU - Federazione Russa 15
MX - Messico 13
RO - Romania 12
EU - Europa 10
CH - Svizzera 9
ES - Italia 8
NL - Olanda 8
AU - Australia 7
CZ - Repubblica Ceca 6
VN - Vietnam 6
CI - Costa d'Avorio 5
BG - Bulgaria 4
BR - Brasile 4
EE - Estonia 4
AT - Austria 3
CL - Cile 3
PT - Portogallo 3
TH - Thailandia 3
DK - Danimarca 2
ID - Indonesia 2
LT - Lituania 2
MD - Moldavia 2
MU - Mauritius 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
PA - Panama 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 9.338
Città #
Chandler 770
Ashburn 374
Jacksonville 285
Dublin 249
San Mateo 235
Ann Arbor 177
Nanjing 153
Wilmington 119
Boston 106
Munich 103
Warsaw 97
Marseille 96
New York 91
Woodbridge 89
Mcallen 83
Lawrence 82
Seattle 80
Dearborn 77
Rome 75
Nürnberg 72
Beijing 71
Bremen 68
Redwood City 68
Houston 67
Fairfield 64
Nanchang 61
Izmir 57
Milan 53
Shenyang 51
Cattolica 49
Princeton 47
Hangzhou 45
Hebei 42
University Park 41
Chicago 40
Zhengzhou 37
Lancaster 36
Brussels 35
Andover 33
Helsinki 32
Tianjin 31
Kraków 30
Mountain View 28
Kunming 27
Changsha 25
Augusta 24
Montréal 24
Hong Kong 22
Norwalk 22
Shanghai 19
Jiaxing 18
Chengdu 17
Fremont 17
Guangzhou 17
Hounslow 17
Kish 17
Ningbo 17
Pune 16
Cambridge 15
Detroit 15
London 13
Boardman 11
Jinan 11
Los Angeles 11
San Giovanni Bianco 11
Singapore 11
Leawood 9
Seongnam 9
San Diego 8
Segrate 8
Changchun 7
Falls Church 7
Hefei 7
Redmond 7
Seoul 7
Timisoara 7
Washington 7
Ardabil 6
Mexico City 6
Santa Maria 6
Taizhou 6
Ypsilanti 6
Abidjan 5
Berlin 5
Buffalo 5
Lanzhou 5
Padova 5
Antwerpen 4
Brescia 4
Costa Mesa 4
Fuzhou 4
Hanoi 4
Millbury 4
Phoenix 4
Portland 4
Ravenna 4
Rimini 4
Simi Valley 4
Tallinn 4
Varna 4
Totale 5.086
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 342
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 290
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 200
Duplex Doppler in the postoperative monitoring of liver transplant recipients 153
Accidental transplantation of a kidney with stones: case report 152
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 136
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 135
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 133
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 127
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 126
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 126
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 110
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 110
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 109
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 107
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 104
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 104
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 100
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 100
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 98
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 97
Model for end-stage liver disease dynamic stratification of survival benefit 96
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 96
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 94
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 93
Prediction of 6-month survival after liver transplantation using Cox regression. 92
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 92
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 91
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 88
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 87
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 87
Psychological risk factors for graft rejection among liver transplant recipients 87
Liver transplantation in patients with alcoholic liver disease: A retrospective study 86
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 85
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 85
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 83
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 82
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 81
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 80
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 78
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 77
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 77
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 76
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 76
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 75
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 73
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 73
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 73
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 72
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 71
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 71
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 71
Primary difunction after liver trasplantation: donor or recipients fault? 70
Clinical problems of the transplanted kidney 68
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 67
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 66
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 65
Is primary nonfunction still a suitable indication for liver retransplantation? 65
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 65
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 65
Celiac axis compression syndrome in liver transplantation 64
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 64
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 63
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 62
Balancing Utility and Need by Means of Donor-to-Recipient Matching: A Challenging Problem. 62
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 62
Cefotetan versus cefoxitin in peritonitis 61
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 61
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 60
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 59
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 59
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 59
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 57
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 57
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 57
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 57
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 56
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 56
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 56
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 56
Should retransplantation still be considered for primary non-function after liver transplantation? 55
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 55
Recovery index: a useful tool for quantification of liver injury after liver transplantation to predict one-year survival 54
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 54
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 54
Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. 53
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 52
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 52
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 51
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 51
Marginal donors for patients on regular waiting lists for liver transplantation 50
Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection 49
Outcome of liver transplatation after acute rejection and sepsis 49
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 48
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 48
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients 48
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 48
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 46
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 46
Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West 44
Totale 8.233
Categoria #
all - tutte 33.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019214 0 0 0 0 0 0 0 0 0 0 96 118
2019/20201.453 254 58 82 92 135 160 186 64 86 98 124 114
2020/20211.111 81 114 14 112 169 50 114 19 132 71 212 23
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/2024971 48 378 25 159 54 118 82 38 15 54 0 0
Totale 9.453